Global longitudinal strain predicts left ventricular dysfunction after mitral valve repair. 2013

Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

OBJECTIVE Despite a successful surgical procedure and adherence to current recommendations, postoperative left ventricular (LV) dysfunction after mitral valve repair (MVr) for organic mitral regurgitation (MR) may still occur. New approaches are therefore needed to detect subclinical preoperative LV dysfunction. LV global longitudinal strain (GLS), assessed with speckle-tracking echocardiographic analysis, has been proposed as a novel measure to better depict latent LV dysfunction. The aim of this study was to investigate the value of GLS to predict long-term LV dysfunction after MVr. RESULTS A total of 233 patients (61% men, 61 ± 12 years) with moderate-severe organic MR who underwent successful MVr between 2000 and 2009 were included. Echocardiography was performed at baseline and long-term follow-up (34 ± 20 months) after MVr. LV dysfunction at follow-up was defined as LV ejection fraction (EF) <50% and was present in 29 (12%) patients. A cut-off value of -19.9% of GLS showed a sensitivity and specificity of 90 and 79% to predict long-term LV dysfunction. By univariate logistic regression analysis, baseline LVEF ≤60%, LV end-systolic diameter (ESD) ≥40 mm, atrial fibrillation, presence of symptoms, and GLS >-19.9% were predictors of long-term LV dysfunction. By multivariate analysis, GLS remained an independent predictor of LV dysfunction (odds ratio 23.16, 95% confidence interval: 6.53-82.10, P < 0.001), together with LVESD. CONCLUSIONS In a large series of patients operated within the last decade, MVr resulted in a low incidence of long-term LV dysfunction. A GLS of >-19.9% demonstrated to be a major independent predictor of long-term LV dysfunction after adjustment for parameters currently implemented into guidelines.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008943 Mitral Valve The valve between the left atrium and left ventricle of the heart. Bicuspid Valve,Bicuspid Valves,Mitral Valves,Valve, Bicuspid,Valve, Mitral,Valves, Bicuspid,Valves, Mitral
D008944 Mitral Valve Insufficiency Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation. Mitral Incompetence,Mitral Regurgitation,Mitral Valve Incompetence,Mitral Insufficiency,Mitral Valve Regurgitation,Incompetence, Mitral,Incompetence, Mitral Valve,Insufficiency, Mitral,Insufficiency, Mitral Valve,Regurgitation, Mitral,Regurgitation, Mitral Valve,Valve Incompetence, Mitral,Valve Insufficiency, Mitral,Valve Regurgitation, Mitral
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
January 2021, Seminars in thoracic and cardiovascular surgery,
Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
May 2009, American heart journal,
Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
August 2022, ESC heart failure,
Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
March 2015, The Journal of thoracic and cardiovascular surgery,
Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
November 2022, European journal of heart failure,
Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
February 2020, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
June 2023, Journal of clinical medicine,
Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
November 2022, The Journal of thoracic and cardiovascular surgery,
Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
September 1995, The Journal of heart valve disease,
Tomasz G Witkowski, and James D Thomas, and Philippe J M R Debonnaire, and Victoria Delgado, and Ulas Hoke, and See H Ewe, and Michel I M Versteegh, and Eduard R Holman, and Martin J Schalij, and Jeroen J Bax, and Robert J M Klautz, and Nina Ajmone Marsan
February 2014, International journal of cardiology,
Copied contents to your clipboard!